Oseltamivir 75 mg Capsules
Designed for systemic antiviral therapy, Oseltamivir 75 mg Capsules are commonly utilized in standard dosing regimens for the treatment and prevention of influenza A and B, in accordance with globally accepted clinical guidance.
Product Details
Therapeutic Class
Neuraminidase Inhibitor (Antiviral)
Indication
Treatment and prophylaxis of influenza A and B infections in adults and adolescents, in accordance with WHO-recommended guidelines.
Dosage & Administration
75 mg twice daily for treatment or 75 mg once daily for prophylaxis, or as prescribed by a healthcare professional.
To be used strictly as per recommended influenza treatment or prophylaxis regimens.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO-recommended treatment guidelines.
Pack Size
10 Capsules
Oseltamivir 75 mg Capsules
Designed for systemic antiviral therapy, Oseltamivir 75 mg Capsules are commonly utilized in standard dosing regimens for the treatment and prevention of influenza A and B, in accordance with globally accepted clinical guidance.
Product Details
Therapeutic Class
Neuraminidase Inhibitor (Antiviral)
Indication
Treatment and prophylaxis of influenza A and B infections in adults and adolescents, in accordance with WHO-recommended guidelines.
Dosage & Administration
75 mg twice daily for treatment or 75 mg once daily for prophylaxis, or as prescribed by a healthcare professional.
To be used strictly as per recommended influenza treatment or prophylaxis regimens.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO-recommended treatment guidelines.
Pack Size
10 Capsules
Oseltamivir 75 mg Capsules
Designed for systemic antiviral therapy, Oseltamivir 75 mg Capsules are commonly utilized in standard dosing regimens for the treatment and prevention of influenza A and B, in accordance with globally accepted clinical guidance.
Product Details
Therapeutic Class
Neuraminidase Inhibitor (Antiviral)
Indication
Treatment and prophylaxis of influenza A and B infections in adults and adolescents, in accordance with WHO-recommended guidelines.
Dosage & Administration
75 mg twice daily for treatment or 75 mg once daily for prophylaxis, or as prescribed by a healthcare professional.
To be used strictly as per recommended influenza treatment or prophylaxis regimens.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO-recommended treatment guidelines.
Pack Size
10 Capsules